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Abstract 
Background: Conjunctival myxoma is a type of rare, benign tumor of mesenchymal cells, 
with fewer than 30 reported cases in the English literature. It is mostly an isolated 
occurrence but can sometimes be associated with systemic diseases such as Carney complex 
or Zollinger-Ellison syndrome. It is necessary in clinical practice to differentiate it from other 
similar lesions, such as amelanotic nevus, lymphangioma, myxoid liposarcoma, spindle-cell 
lipoma, myxoid neurofibroma, and rhabdomyosarcoma.  
Case Presentation: The usual presentation of conjunctival myxoma is a translucent, well-
circumscribed, and painless conjunctival mass, but in this report we discuss an unusual case 
of conjunctival myxoma in a 47-year-old Taiwanese woman who presented initially with pain 
and redness. This atypical presentation complicated the diagnosis and the management at 
first. Surgical excision of the mass was performed. The mass was found to be a conjunctival 
myxoma. The patient subsequently underwent extensive evaluation but was found not to 
have any systemic diseases with known association with conjunctival myxoma.  
Conclusions: In summary, we present a case of conjunctival myxoma in a 47-year-old 
Taiwanese woman. The initial presentation with pain and redness was atypical for 
conjunctival myxoma. The lesion was successfully managed with complete excisional biopsy. 
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Introduction 
Myxoma is a type of benign tumor derived from primitive mesenchymal cells. It is 
the most common primary tumor found in the heart [1]. Myxoma can also arise in other 
locations, including bone, skin, skeletal muscles, gastrointestinal system, and 
genitourinary systems. In the eye, myxomas have been found to involve the orbit, the 
cornea, and the conjunctiva [2, 3]. Conjunctival myxoma is extremely rare, representing 
only one case among the 1,643 conjunctival lesions surveyed in a study (<0.001%) [4]. 
We have found only 26 cases reported in the English literature. The typical 
presentation of conjunctival myxoma is a painless, circumscribed, rubbery, 
translucent/solid, yellow-pink mass or cyst [5–8]. Diseases that may resemble 
conjunctival myxoma include amelanotic nevus, lymphangioma, myxoid liposarcoma, 
spindle-cell lipoma, myxoid neurofibroma, and rhabdomyosarcoma [9]. In this report, 
we describe a case of conjunctival myxoma in a 47-year-old Taiwanese woman with an 
atypical initial presentation of pain and redness. 
Case Presentation 
A 47-year-old Taiwanese woman had a 3-year history of redness in her left eye prior to the initial 
visit. During these 3 years, she had been using unspecified kinds of ophthalmic drops sporadically. 
One month prior to the visit, she began to experience pain and irritation in her left eye and was 
diagnosed with allergic conjunctivitis and treated with cromolyn at another clinic. Her symptoms 
persisted for one month with no improvement from the treatment. Her past medical history was only 
significant for hypertension; she denied any ocular trauma in the past. 
During the initial visit at our clinic, her visual acuity with correction was 1.0 in both eyes. A 6 × 
4 mm mass with surrounding hyperemia was noted in the left eye, situated on the bulbar conjunctiva 
and 0.5 mm temporal to the limbus at 3 o’clock (fig. 1). No proptosis was observed. The rest of the 
ophthalmologic examination was unremarkable. The patient had no other history of ocular pathology. 
The initial impression was scleritis, given the erythema of the left eye conjunctiva. Topical steroid was 
prescribed; the patient was also referred to a rheumatologist for further workup. She returned one 
month later with no improvement in her symptom. The result of an autoimmune panel was within 
normal limit (erythrocyte sedimentation rate, ESR = 12 mm/h, normal: 0–28.5; IgA = 191 mg/dl, 
normal: 70–360; antinuclear antibody, ANA = negative, normal: negative; rheumatoid factor, RF <20 
U/ml, normal: <20 U/ml). By the time of her second visit, the color of the mass had turned salmon-
pink. The patient received an ultrasound B scan to rule out intraocular tumor, but it showed no mass. 
Since the mass persisted in spite of topical steroid treatment and a negative rheumatological workup, 
malignant lymphoma was suspected. The differential diagnosis also included amelanotic nevus, 
dermoid, myxoma, and lipoma. The lesion was subsequently excised and sent for histopathological 
study. 
The specimen consisted of a pinkish tan and soft tissue fragment, measuring 9 × 6 × 4 mm. 
Histopathological examination revealed a benign tumor composed of spindle cells embedded in a 
myxomatous stroma. No nuclear atypia was seen (fig. 2). The tumor cells stained positive for 
vimentin (fig. 3). The findings were consistent with conjunctival myxoma. The patient returned after 
one month post-excision for follow-up and no longer complained of pain and redness in her left eye. 
The patient also received extensive cardiac and endocrine workup. Her echocardiogram showed no 
mass in the heart. The endocrine workup was only remarkable for a mildly depressed T3 level (0.75 
ng/ml, normal: 0.8–2); TSH, T4, estradiol, and FSH were all within normal limits (T4 = 8.47 μg/dl, 
normal: 5.1–14.1; TSH = 1.95 μIU/ml, normal: 0.27–4.2; estradiol = 13.20 pg/ml, normal: <54.7 pg/ml; 
FSH = 100.40 mIU/ml, normal: 25.8–134.8). She had no atypical dermatological findings.  
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Discussion 
Conjunctival myxoma is rare, with only 26 cases reported so far in the English 
literature (table 1). It occurs equally frequently in both sexes; the ages of the patients 
ranged from 11 to 80 years, with a median of 50 [5–8]. Chen et al. [6] reported the 
youngest case in an 11-year-old boy; the other cases were in the range of 18–80 years 
of age. The typical presentation is a translucent, well-circumscribed conjunctival mass, 
most often at the bulbar conjunctiva. Whereas the masses were painless in the 
previously reported cases, the patient in this report presented with pain and redness 
that resembled scleritis; in addition, the margin of the mass was more diffuse than in 
previously reported cases. It is possible that these symptoms resulted from the 
medication used by the patient prior to her initial visit, rather than from an actual 
variation in the presentation of conjunctival myxoma. To our knowledge, only one 
paper published in Japanese had ocular pain as the initial sign of conjunctival myxoma; 
no redness was noted in that case, however, unlike in our case [10]. 
According to a detailed study and literature review by Demirci et al. [5], conjunctival 
myxoma consists of scattered, relatively small stellate- and spindle-shaped cells 
embedded in myxoid matrix along with reticulin fibers, sparse vascular structures, and 
mature collagen fibers. Hyaluronic acid, along with some chondroitin sulfate, 
constituted the matrix. Conjunctival myxomas stain positive with Alcian blue and 
vimentin, and negative with S-100 protein, desmin, and smooth muscle-specific actin 
[8]. 
It is important to differentiate conjunctival myxoma from other similar lesions, 
which include nevus, amelanotic melanoma, lymphangioma, myxoid liposarcoma, 
spindle-cell lipoma, myxoid neurofibroma, and rhabdomyosarcoma. Compared to nevus 
and lymphangioma, myxoma does not have cysts [9]. In addition, lymphangioma and 
amelanotic nevus are highly vascular. Liposarcoma is similar to myxoma in being highly 
mucoid; however, myxoma does not contain pleomorphic multivacuolated lipoblasts or 
signet ring cells. Spindle-cell lipoma tends to be more yellowish and contains mature fat 
cells and signet ring cells when compared to myxoma [11]. 
The recommended management for conjunctival myxoma is complete excisional 
biopsy [5]. No cases of recurrence or malignant transformation have been reported. 
While most reported cases of conjunctival myxoma were isolated occurrences, at 
least two had systemic involvement and presented as a component of Carney complex 
or in association with Zollinger-Ellison syndrome [12, 13]. Carney complex is an 
autosomal dominant syndrome first described in the mid-1980s. It can present with 
multiple endocrine tumors involving the adrenal, pituitary, and thyroid glands, or with 
Cushing syndrome; it is also associated with many other non-endocrine tumors, such as 
cardiac myxomas, breast myxomas, testicular tumors, melanotic schwannoma, and 
abnormal pigmentation. The Carney complex gene 1 had been identified as the 
regulatory subunit 1A of protein kinase A (PRKAR1A) located at 17q22–24 [14]. In 
addition to Carney complex, myxoma may also be a component of the Mazabraud 
syndrome (bone fibrous dysplasia and intramuscular myxoma) or of the McCune-
Albright syndrome (café au lait spots and multinodular goiter) [5]. As a result of these 
associations, systemic evaluation of a patient with conjunctival myxoma, which 
includes cardiac echocardiography and analysis of hormone levels, is warranted.  
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In summary, we present a case of conjunctival myxoma in a 47-year-old Taiwanese 
woman. The diagnosis was somewhat complicated by the atypical presentation with 
pain and redness, but the histopathological and immunochemical findings were 
consistent with those of conjunctival myxoma. The lesion was successfully managed 
with complete excisional biopsy. 
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Table 1. The list of reported conjunctival myxoma cases published in English, adapted from Demirci et 
al. [5], updated with cases reported after the original publication 
                     
                     
Source  Age, years/ 
sex 
Systemic disease  Eye  Symptoms  Clinical features    Color  Conjunctival 
site 
Conjunctival 
location 
Outcome 
                     
                     
Ffooks (1962)  72/M  None  OD  Conjunctival mass  Rubbery, circumscribed 
subconjunctival mass 
  White  Limbus  Superior  Stable 
Doughman and Wenk 
(1970) 
49/F  None  OD  Conjunctival mass  Rubbery, circumscribed 
subconjunctival mass 
  Yellow  Limbus  Temporal  Stable 
Stafford (1971)  54/F  None  OD  Conjunctival cyst  Translucent, circumscribed 
subconjunctival mass 
  Pink  Limbus  Temporal  Stable 
Patrinely and Green 
(1983) 
50/F  None  OD  Conjunctival mass  Translucent, diffuse conjunctival mass   Yellow  Bulbar  Nasal  Stable 
  53/F  None  OS  Conjunctival cyst  Solid, circumscribed conjunctival mass   Yellow  Bulbar  Temporal  Stable 
  18/F  None  OS  Conjunctival mass  Semitranslucent, circumscribed 
conjunctival mass 
  Pink  Bulbar  Superior  Stable 
  42/F  None  OD  Conjunctival mass  Translucent, circumscribed 
subconjunctival mass 
  Yellow  Limbus  Temporal  Stable 
Mottow-Lippa et al. 
(1983) 
54/M  None  OS  Conjunctival mass  Translucent, circumscribed 
subconjunctival mass 
  Pink  Limbus  Temporal  Stable 
Pe'er et al. (1984)  18/F  None  OD  Conjunctival mass  Translucent, circumscribed 
subconjunctival mass 
  Pink  Bulbar  Nasal  Stable 
Pe'er and Hidayat (1986)  48/M  None  NA  Conjunctival cyst  Conjunctival cyst    Yello  Fornix  Inferior  Stable 
  61/M  None  NA  Conjunctival 
growth 
Solid, circumscribed subconjunctival 
mass 
  NA  Bulbar  Temporal  Stable 
  34/M  None  NA  Conjunctival cyst  Conjunctival cyst    Yellow  Bulbar  Temporal  Stable 
  64/M  None  NA  Conjunctival mass  Conjunctival mass    Pink  Bulbar  Temporal  Stable 
  33/F  None  NA  Conjunctival mass  Solid, circumscribed conjunctival mass   Pink  Bulbar  NA  Stable 
  20/M  None  NA  Conjunctival cyst  Translucent, circumscribed 
conjunctival mass 
  Yellow  Limbus  Temporal  Stable 
  50/M  None  NA  Conjunctival cyst  Translucent, circumscribed 
conjunctival mass 
  Yellow  Bulbar  Nasal  Stable 
  50/F  None  NA  Conjunctival mass  Solid, circumscribed conjunctival mass   Pink  Bulbar  NA  Stable 
  76/M  None  NA  Conjunctival cyst  Translucent, circumscribed 
conjunctival mass 
  NA  Limbus  Superior  Stable 
  65/F  None  NA  Conjunctival mass  Translucent, diffuse conjunctival mass   NA  Bulbar  Temporal  Stable 
Kennedy et al. (1987)  23/M  Carney complex  NA  Conjunctival mass  Translucent, circumscribed 
conjunctival mass 
  Yellow  Palpebral  Superior  Stable 
Horie et al. (1995)  80/F  None  OS  Conjunctival mass  Solid, circumscribed conjunctival mass   NA  Bulbar  Nasal  Stable 
Ramaesh et al. (2001)  36/M  Zollinger-Ellison 
syndrome and thickness 
of atrial septum 
OD  Conjunctival 
swelling 
Translucent, circumscribed 
conjunctival mass 
  Pink  Bulbar  Nasal  Stable 
Demirci et al. (2006)  31/M  None  OS  Conjunctival 
swelling 
Translucent, circumscribed 
conjunctival mass 
  Yellow-pink  Bulbar  Nasal  Stable 
Chen et al. (2008)  11/M  None  OS  Conjunctival mass  Translucent, circumscribed 
conjunctival mass 
  Yellow-pink  Bulbar  Temporal  Stable 
Arya et al. (2008)  64/F  None  OD  Conjunctival 
swelling 
Translucent, circumscribed 
conjunctival mass 
  Yellow-pink  Bulbar  Superonasal  Stable 
Kiliç et al. (2008)  45/F  None  OS  Conjunctival mass  Translucent, circumscribed 
conjunctival mass 
  Yellow-pink  Bulbar  Temporal  Stable 
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Fig. 1. A circumscribed mass in the temporal bulbar conjunctiva of the left eye, surrounded by region 
of hyperemia. 
 
 
 
Fig. 2. Scattered spindle cells embedded in a myxomatous stroma (hematoxylin-eosin, original 
magnification ×200). 
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Fig. 3. Tumor cells staining positive for vimentin (immunoperoxidase, original magnification ×100). 
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